Document ID: chunk:federal_register_of_legislation:C2010A00126:clause:2_99aco
Version: federal_register_of_legislation:C2010A00126
Segment Type: clause
Provision Reference: sch 2 cl 99ACO
Character Range: 27162–28051

99ACO  5% statutory price reduction for brands of pharmaceutical items having a drug that is not subject to outstanding staged reductions
  If:
 (a) on 31 January 2011, a price agreement or a determination under section 85B is in force in relation to a listed brand (the relevant brand) of a pharmaceutical item (the relevant item); and
 (b) on 11 October 2010, the drug in the relevant item was in Part T of F2; and
 (c) on 1 February 2011, the relevant item is not an exempt item; and
 (d) on 1 February 2011, the relevant brand of the relevant item is not subject to an outstanding staged reduction; and
 (e) on 1 February 2011, there is not another listed brand of a pharmaceutical item that:
 (i) is subject to an outstanding staged reduction; and
 (ii) has the same drug as the relevant item;
then this section applies to the relevant brand of the relevant item on 1 February 2011.